KLEIN/JOHNSON GROUP for CVS HEALTH
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Labor Issues/Antitrust/Workplace LBR
- Issues related to CVS Healths acquisition of Aetna - Issues related to the competitive nature of the pharmacy benefit management industry. - H.R. 2376/S. 1227, The Prescription Pricing for the People Act of 2019
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LEE JOHNSON | Chief Counsel, Sen. John Cornyn; Senate Judiciary Committee |
| ISRAEL S KLEIN | Deputy Staff Director, Joint Economic Committee, Chairman Chuck Schumer; Senior Communications Advisor, Representative Ed Markey; Communications Director, Senator Chuck Schumer; Press Secretary and Legislative Assistant, Representative Ed Markey |
Copyright/Patent/Trademark CPT
- Issues related to barriers to generic drug and biosmiliar market entry including pay-for-delay and REMS. - S. 64, The Preserve Access to Affordable Generics Act of 2019 - S. 340/H.R. 965, The Creating and Restoring Equal Access to Equivalent Samples Act of 2019 - S. 659, The Biologic Patent Transparency Act of 2019
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW LEE JOHNSON | Chief Counsel, Sen. John Cornyn; Senate Judiciary Committee |
| ISRAEL S KLEIN | Deputy Staff Director, Joint Economic Committee, Chairman Chuck Schumer; Senior Communications Advisor, Representative Ed Markey; Communications Director, Senator Chuck Schumer; Press Secretary and Legislative Assistant, Representative Ed Markey |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.